GlenLine’s primary focus is the acquisition and active asset management of urban infill industrial, flex, life science and mixed-use properties with long-term value and optionality for repositioning or redevelopment.
Fishers Court, Rockville, MD
60,000 SF flex/industrial with 160,000 SF redevelopment potential
(acquired Q3 2019)
(sold Q4 2021)
1901 4th St, NE, Washington, DC
34,000 SF transit oriented infill industrial with long term redevelopment potential
(acquired Q3 2019)
Woodglen, North Bethesda, MD
200,000 SF, 3.8-acre lab and office complex with 740,000 SF redevelopment potential
(acquired Q2 2020)
700 Evelyn, Linthicum, MD
180,000 SF bulk industrial
(acquired Q4 2020)
TwinLabs, Rockville, MD
80,000 SF lab repositioning (acquired Q4 2020)
Confidential, Silver Spring, MD
150,000 SF prospective cGMP/R&D Facility
(Q3 2021)
5811 Allender, White Marsh, MD
82,000 SF industrial redevelopment
(acquired Q4 2021)
GLI Beltsville Portfolio
3-Asset Industrial and Service Retail 93,000 SF industrial redevelopment
(acquired Q2 2022)
TwinLabs is the former home of a National Institute of Allergy and Infectious Diseases research facility. GlenLine is significantly renovating the existing structures and will deliver 80k SF of market leading BSL-2 lab space in 2021.
Woodglen Drive is a 63,275 SF building containing a 20k SF BSL-2 facility built for the Department of Defense Bone Marrow Program. It's part of a mixed-used project approved for 740k SF of additional density.
Fishers Court is a 60,600 SF, cGMP and flex-industrial project adjacent to NIAID and HHS. GlenLine stabilized and successfully exited the investment in 2022.
GlenLine's sister company, Minkoff Development Corporation developed and operates Propel Labs, a BSL-2 incubator space for growing life science companies in the heart of the Shady Grove life science cluster.
